tirzepatide gip glp 1 Beyond glycemia: Comparing to GLP-1 analogues Tirzepatide 10mg — GLP-1/GIP Dual-Agonist

Understanding your genetic predisposition helps your provider select not just the delivery form, but the starting dose and escalation timeline most likely to work for your biology

Common (affecting up to 1 in 10 people, usually settling after a few weeks) Uncommon or rare (affecting up to 1 in 100 - or 1 in 1000 if rare - people, contact a doctor if severe) Nausea, diarrhoea, constipation, indigestion, tummy pain, reduced appetite, vomiting, injection-site reactions, dizziness, hair loss Gallstones,pancreatitis (severe abdominal or back pain),injection-site pain, serious allergy, changed sense of taste, change in skin sensation

And no, these medications dont cause muscle loss

Individual experiences and risks vary